Artwork

Contenu fourni par Healio, Adam J. Brown, and MD. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Healio, Adam J. Brown, and MD ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Player FM - Application Podcast
Mettez-vous hors ligne avec l'application Player FM !

The Rheumatologist, Cancer and the Breakthrough, Part 2

33:49
 
Partager
 

Manage episode 407440421 series 3560282
Contenu fourni par Healio, Adam J. Brown, and MD. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Healio, Adam J. Brown, and MD ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

In this episode, Leonard H. Calabrese, DO, is joined by his colleague and daughter Cassandra Calabrese, DO, as they discuss specifics of irAEs, including unusual toxicities, rheumatic conditions associated with checkpoint inhibitors and the rheumatologist’s role in this new area of medicine.

Brought to you by GSK. Considering a treatment change for patients with active SLE? Learn about a treatment option for your patients at treatfortodayandtomorrow.com.

  • Intro :22
  • Recap of Part 1 :40
  • An interview with Cassandra Calabrese, DO 2:02
    • The number of patients with irAEs will grow 2:22
    • How many people actually experience irAEs? 3:40
    • Any examples of unusual toxicities? 5:49
    • What’s the timeline? 6:51
    • Have you seen patients with delayed onset? 8:10
    • Most of our patients have had one irAE or another beforehand 9:04
    • Who’s the captain of this ship? 10:15
    • What about inflammatory arthritis? 10:55
    • What about polymyalgia rheumatica? 13:48

Brought to you by GSK. Consider the long-term impact of disease activity, flares and corticosteroid use on patients with active SLE. Learn more now at treatfortodayandtomorrow.com

  • What about sicca, is it Sjogren’s? 16:22
  • Can you tell us about myositis in this context? 18:38
  • An overview of the guidelines 21:47
  • Check out our article in March Current Opinions in Rheumatology 24:12
  • What about patients with preexisting autoimmunity? 24:33
  • Are you worried about blunting tumor response? 27:10
  • Are there any biomarkers to predict this? 28:30
  • How have you been working with oncologists to manage/educate? 29:42
  • What about meetings? 31:04
  • Rheumatologists have a special place in this new area of medicine 31:45

We’d love to hear from you! Send your comments/questions to rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum @LCalabreseDO @CCalabreseDO

Disclosure: Brown and Cassandra Calabrese report no relevant financial disclosures. Leonard Calabrese reports serving as an investigator and a consultant to Horizon Pharmaceuticals.

Cassandra Calabrese, DO, is associate staff member in the department of rheumatic and immunologic disease and department of infectious disease at the Cleveland Clinic. Leonard H. Calabrese, DO, is chief medical editor of Healio Rheumatology and director of the RJ Fasenmyer Center for Clinical Immunology at the Cleveland Clinic.

  continue reading

86 episodes

Artwork
iconPartager
 
Manage episode 407440421 series 3560282
Contenu fourni par Healio, Adam J. Brown, and MD. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Healio, Adam J. Brown, and MD ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

In this episode, Leonard H. Calabrese, DO, is joined by his colleague and daughter Cassandra Calabrese, DO, as they discuss specifics of irAEs, including unusual toxicities, rheumatic conditions associated with checkpoint inhibitors and the rheumatologist’s role in this new area of medicine.

Brought to you by GSK. Considering a treatment change for patients with active SLE? Learn about a treatment option for your patients at treatfortodayandtomorrow.com.

  • Intro :22
  • Recap of Part 1 :40
  • An interview with Cassandra Calabrese, DO 2:02
    • The number of patients with irAEs will grow 2:22
    • How many people actually experience irAEs? 3:40
    • Any examples of unusual toxicities? 5:49
    • What’s the timeline? 6:51
    • Have you seen patients with delayed onset? 8:10
    • Most of our patients have had one irAE or another beforehand 9:04
    • Who’s the captain of this ship? 10:15
    • What about inflammatory arthritis? 10:55
    • What about polymyalgia rheumatica? 13:48

Brought to you by GSK. Consider the long-term impact of disease activity, flares and corticosteroid use on patients with active SLE. Learn more now at treatfortodayandtomorrow.com

  • What about sicca, is it Sjogren’s? 16:22
  • Can you tell us about myositis in this context? 18:38
  • An overview of the guidelines 21:47
  • Check out our article in March Current Opinions in Rheumatology 24:12
  • What about patients with preexisting autoimmunity? 24:33
  • Are you worried about blunting tumor response? 27:10
  • Are there any biomarkers to predict this? 28:30
  • How have you been working with oncologists to manage/educate? 29:42
  • What about meetings? 31:04
  • Rheumatologists have a special place in this new area of medicine 31:45

We’d love to hear from you! Send your comments/questions to rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum @LCalabreseDO @CCalabreseDO

Disclosure: Brown and Cassandra Calabrese report no relevant financial disclosures. Leonard Calabrese reports serving as an investigator and a consultant to Horizon Pharmaceuticals.

Cassandra Calabrese, DO, is associate staff member in the department of rheumatic and immunologic disease and department of infectious disease at the Cleveland Clinic. Leonard H. Calabrese, DO, is chief medical editor of Healio Rheumatology and director of the RJ Fasenmyer Center for Clinical Immunology at the Cleveland Clinic.

  continue reading

86 episodes

Tous les épisodes

×
 
Loading …

Bienvenue sur Lecteur FM!

Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.

 

Guide de référence rapide

Écoutez cette émission pendant que vous explorez
Lire